Impaired Fasting Glucose and Impaired Glucose Tolerance
David M. Nathan, Mayer B. Davidson, Ralph A. DeFronzo, Robert J. Heine, Robert R. Henry, Richard E. Pratley, Bernard Zinman
Abstract
Open-access reader
David M. Nathan, Mayer B. Davidson, Ralph A. DeFronzo, Robert J. Heine, Robert R. Henry, Richard E. Pratley, Bernard Zinman
Abstract
Open-access reader
Reduction Assessment with Ramipril and Rosiglitazone Medication; FPG, fasting plasma glucose; IGT, impaired glucose tolerance; IFG, impaired fasting glucose; NGT, normal glucose tolerance; OGTT, oral glucose tolerance test.A table elsewhere in this issue shows conventional
OpenAlex reports 1400 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Reduction Assessment with Ramipril and Rosiglitazone Medication; FPG, fasting plasma glucose; IGT, impaired glucose tolerance; IFG, impaired fasting glucose; NGT, normal glucose tolerance; OGTT, oral glucose tolerance test.A table elsewhere in this issue shows conventional
Key concepts: Medicine, Impaired glucose tolerance, Impaired fasting glucose, Diabetes mellitus, Internal medicine, Endocrinology, Glucose tolerance test, Type 2 diabetes